Form 4: Health Catalyst CFO Sells Shares to Cover Tax Obligations

Health Catalyst's Chief Financial Officer, Jason Alger, sold 7,795 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Summary

• Jason Alger, the Chief Financial Officer of Health Catalyst, Inc., sold 7,795 shares of common stock on December 1, 2024.
• The sale was executed at a price of $8.9732 per share.
• This transaction was not a discretionary trade but was mandated by the company's equity incentive plan to cover tax withholding obligations.
• Following the transaction, Mr. Alger directly owns 106,311 shares of Health Catalyst stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and tax obligations. It is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It does not indicate any change in the company's performance or outlook.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly traded companies.
• Many companies use 'sell to cover' mechanisms as part of their equity compensation plans.
• This type of transaction is not unusual and is generally not indicative of a change in the company's financial health or prospects.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• The sale does not indicate any change in the company's performance or outlook.

Key Dates

Keywords

Health Catalyst, HCAT, insider trading, stock sale, tax obligations, restricted stock units, CFO, Jason Alger